Seven Fleet Capital Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.79M Buy
220,126
+91,958
+72% +$2.72M 1.29% 18
2026
Q1
$3.55M Buy
+128,168
New +$3.29M 1.12% 23

Other funds holding ROIV

Seven Fleet Capital Management's ROIV Position: Q2 2026 in Review

Seven Fleet Capital Management increased its Roivant Sciences (ROIV) stake by 72% in Q2 2026, buying an estimated $2.72M and bringing the position to 220,126 shares worth $7.79M. The position accounts for 1.29% of the portfolio, ranked #18.

Seven Fleet Capital Management first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Seven Fleet Capital Management held 220,126 shares of Roivant Sciences worth $7.79M as of Q2 2026.
  • Seven Fleet Capital Management bought 91,958 Roivant Sciences shares in Q2 2026, an estimated $2.72M.
  • Roivant Sciences made up 1.29% of Seven Fleet Capital Management's portfolio in Q2 2026, its #18 holding.
  • Seven Fleet Capital Management first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.